Skip to main content

Functional Motor Disorders

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
2 programs
Multidisciplinary Rehabilitation TrainingN/A1 trial
Virtual Reality interventionN/A1 trial
Active Trials
NCT06328790Unknown450Est. May 2025
NCT05581134Unknown36Est. Sep 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Verona PharmaMultidisciplinary Rehabilitation Training
Verona PharmaVirtual Reality intervention

Clinical Trials (2)

Total enrollment: 486 patients across 2 trials

NCT06328790Verona PharmaMultidisciplinary Rehabilitation Training

Study of Biomorkers and Rehabilitation Strategies in Functional Motor Disorders (FMD)

Start: May 2023Est. completion: May 2025450 patients
N/AUnknown
NCT05581134Verona PharmaVirtual Reality intervention

Immersive Virtual Reality in Functional Motor Disorders

Start: Sep 2022Est. completion: Sep 202336 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.